These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38027142)

  • 21. Concomitant systemic lupus erythematosus might have a negative impact on the biochemical responses to treatment in patients with primary biliary cholangitis.
    Fan X; Men R; Ni P; Lu C; Si T; Ma Y; Yang L
    Clin Rheumatol; 2020 Mar; 39(3):795-803. PubMed ID: 31807995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Underestimated Male Prevalence of Primary Biliary Cholangitis in China: Results of a 16-yr cohort study involving 769 patients.
    Fan X; Wang T; Shen Y; Xi X; Yang L
    Sci Rep; 2017 Jul; 7(1):6560. PubMed ID: 28747696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using two-step cluster analysis to classify inpatients with primary biliary cholangitis based on autoantibodies: A real-world retrospective study of 537 patients in China.
    Zhao DT; Yan HP; Liao HY; Liu YM; Han Y; Zhang HP; Zhang WM; Huang CY; Liu XH; Lou JL; Zhao Y
    Front Immunol; 2022; 13():1098076. PubMed ID: 36685575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis.
    Bossen L; Rebora P; Bernuzzi F; Jepsen P; Gerussi A; Andreone P; Galli A; Terziroli B; Alvaro D; Labbadia G; Aloise C; Baiocchi L; Giannini E; Abenavoli L; Toniutto P; Marra F; Marzioni M; Niro G; Floreani A; Møller HJ; Valsecchi MG; Carbone M; Grønbaek H; Invernizzi P
    Liver Int; 2020 Jun; 40(6):1408-1414. PubMed ID: 32279422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight.
    Cossiga V; Cazzagon N; Montalti R; Ciminnisi S; Attanasio MR; Pezzato F; Giacchetto M; Guarino M; Calvaruso V; Floreani A; Morisco F
    Dig Liver Dis; 2023 Jun; 55(6):778-784. PubMed ID: 36593159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort.
    Marschall HU; Henriksson I; Lindberg S; Söderdahl F; Thuresson M; Wahlin S; Ludvigsson JF
    Sci Rep; 2019 Aug; 9(1):11525. PubMed ID: 31395896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients.
    Zografos TA; Gatselis N; Zachou K; Liaskos C; Gabeta S; Koukoulis GK; Dalekos GN
    World J Gastroenterol; 2012 Sep; 18(34):4721-8. PubMed ID: 23002341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinically significant portal hypertension in patients with primary biliary cholangitis: Clinicopathological features and prognostic value.
    Zhang Y; Lai H; Chen J; Lai R; Lin X; Lin S; Liu B; Lin Q; Wang B; Zheng Q
    Ann Hepatol; 2024 Sep; 30(1):101577. PubMed ID: 39276989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implication of increased serum stromal cell-derived factor-1 for primary biliary cholangitis.
    Yang Z; Liang Y; Lin F; Zhang Z; Luo W; Zhang Y; Zhong R
    Int Immunopharmacol; 2018 Mar; 56():285-290. PubMed ID: 29414663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease.
    Silveira MG; Mendes FD; Diehl NN; Enders FT; Lindor KD
    Liver Int; 2009 Aug; 29(7):1094-100. PubMed ID: 19291181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China.
    Shen ZX; Wu DD; Xia J; Wang XB; Zheng X; Huang Y; Li BL; Meng ZJ; Gao YH; Qian ZP; Liu F; Lu XB; Shang J; Yan HD; Zheng YB; Gu WY; Zhang Y; Wei JY; Tan WT; Hou YX; Zhang Q; Xiong Y; Zou CC; Chen J; Huang ZB; Jiang XH; Luo S; Chen YY; Gao N; Liu CY; Yuan W; Mei X; Li J; Li T; Zhou XY; Deng GH; Chen JJ; Ma X; Li H
    World J Gastroenterol; 2022 Aug; 28(31):4417-4430. PubMed ID: 36159019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The overlap with metabolic dysfunction-associated steatotic liver disease negatively affects outcomes of primary biliary cholangitis.
    Hernández-Pérez M; Riado D; Pena E; Méndez C; Pinedo F; Ramos P; Castillo P; Romero M; Fernández-Rodríguez C; Olveira A
    Aliment Pharmacol Ther; 2024 Sep; 60(5):613-619. PubMed ID: 38924185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis.
    Chen S; Li MQ; Duan WJ; Li BE; Li SX; Lv TT; Ma L; Jia JD
    Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):577-582. PubMed ID: 35668014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
    John BV; Khakoo NS; Schwartz KB; Aitchenson G; Levy C; Dahman B; Deng Y; Goldberg DS; Martin P; Kaplan DE; Taddei TH
    Am J Gastroenterol; 2021 Sep; 116(9):1913-1923. PubMed ID: 33989225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of Noninvasive Fibrosis Scores in Primary Biliary Cholangitis.
    Qu Y; Wang L; Ye Q; Zhang Y; Xiao J; Li T
    J Coll Physicians Surg Pak; 2019 Nov; 29(11):1101-1105. PubMed ID: 31659971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis.
    Jin Y; Wang M; Liu Y; Xu A
    Medicine (Baltimore); 2023 Oct; 102(42):e35617. PubMed ID: 37861502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.
    Montano-Loza AJ; Hansen BE; Corpechot C; Roccarina D; Thorburn D; Trivedi P; Hirschfield G; McDowell P; Poupon R; Dumortier J; Bosch A; Giostria E; Conti F; Parés A; Reig A; Floreani A; Russo FP; Goet JC; Harms MH; van Buuren H; Van den Ende N; Nevens F; Verhelst X; Donato MF; Malinverno F; Ebadi M; Mason AL;
    Gastroenterology; 2019 Jan; 156(1):96-107.e1. PubMed ID: 30296431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland.
    Terziroli Beretta-Piccoli B; Stirnimann G; Cerny A; Semela D; Hessler R; Helbling B; Stickel F; Kalid-de Bakker C; Bihl F; Giostra E; Filipowicz Sinnreich M; Oneta C; Baserga A; Invernizzi P; Carbone M; Mertens J
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):295-306. PubMed ID: 29181702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased Risks of Spontaneous Bacterial Peritonitis and Interstitial Lung Disease in Primary Biliary Cirrhosis Patients With Concomitant Sjögren Syndrome.
    Chen CT; Tseng YC; Yang CW; Lin HH; Chen PJ; Huang TY; Shih YL; Chang WK; Hsieh TY; Chu HC
    Medicine (Baltimore); 2016 Jan; 95(2):e2537. PubMed ID: 26765478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis.
    Efe C; Taşçilar K; Henriksson I; Lytvyak E; Alalkim F; Trivedi H; Eren F; Eliasson J; Beretta-Piccoli BT; Fischer J; Calişkan AR; Chayanupatkul M; Coppo C; Ytting H; Purnak T; Muratori L; Werner M; Muratori P; Rorsman F; Önnerhag K; Günşar F; Nilsson E; Heurgué-Berlot A; Güzelbulut F; Demir N; Gönen C; Semela D; Aladağ M; Kiyici M; Schiano TD; Montano-Loza AJ; Berg T; Ozaslan E; Yoshida EM; Bonder A; Marschall HU; Wahlin S
    Am J Gastroenterol; 2019 Jul; 114(7):1101-1108. PubMed ID: 31241547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.